Effect of Lanadelumab on Coagulation Parameters in Patients With Hereditary Angioedema: Findings From the Phase 3 HELP Study

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.123
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Lanadelumab and Cardiovascular Risk: Findings From the Phase 3 HELP Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Exposure-Response Analyses of Lanadelumab in Patients With Hereditary Angioedema

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Efficacy and Safety of Lanadelumab for Prophylactic Treatment in Adolescents With Hereditary Angioedema (HAE)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

The Effect of Long-Term Danazol Treatment on Haematological Parameters in Hereditary Angioedema

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2016English

Relationship Between Body Weight, PK/PD, and Attack Responses Following Subcutaneous Administration of Lanadelumab in Patients With Hereditary Angioedema

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Socioeconomic Burden of Hereditary Angioedema: Results From the Hereditary Angioedema Burden of Illness Study in Europe

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2014English

The Predictability of Attacks in Patients With Hereditary Angioedema

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Ongoing Contact Activation in Patients With Hereditary Angioedema

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy